Research suggests that kudzu root (Pueraria lobata) has a history of traditional use for headache-related conditions, and some clinical and mechanistic evidence lends preliminary support to this application. A 2009 clinical study reported that kudzu extract reduced the intensity, frequency, and duration of cluster headache attacks in a notable proportion of patients, while a 2023 study examined a kudzu-based traditional formula for migraine treatment and explored its underlying mechanisms. Supporting context comes from a 2019 review identifying kudzu's isoflavonoid compounds as active components relevant to migraine and stroke remedies, and a 2025 source documenting its traditional use for fever with headache and dizziness. The available body of evidence is small, relies heavily on traditional use records and limited clinical data rather than large randomized controlled trials, and should be interpreted cautiously until more rigorous research is conducted.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Response of cluster headache to kudzu. | Other | 2009 | Supports | 97 |
| Network pharmacology and experimental verification to explore the anti-migrai... | Other | 2023 | Supports | 92 |
| Applications of Pueraria lobata in treating diabetics and reducing alcohol dr... | Other | 2019 | Supports | 75 |
| Network pharmacology combines cellular experiments to investigate the anti-in... | Other | 2025 | Supports | 60 |